Published in Cancer Weekly, June 12th, 1995
The results of a Phase II trial was presented by researchers from the University of Texas M.D. Anderson Cancer Center in Houston and The University of Texas Health Science Center in San Antonio at the Annual Meeting of the American Society of Clinical Oncology (ASCO), held May 22, 1995, in Los Angeles, California.
A preliminary analysis of an additional study also showed that Docetaxel can have activity in patients who have previously failed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.